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Toshikazu Takeshita, Tomikazu Arita, Masaya Higuchi, induction independent of Syk. Jak3 is essential for IL-
2-mediated induction of DNA synthesis and proto-onco-Hironobu Asao, Kazuhiro Endo, Hiroshi Kuroda,
Nobuyuki Tanaka, Kazuko Murata, Naoto Ishii, genes such as c-myc and c-fos (Miyazaki et al., 1994;
Kawahara et al., 1995), and Stat5 is activated by Jak3and Kazuo Sugamura
Department of Microbiology for efficient transcription of its target genes (Johnston
et al., 1995;Wakao et al., 1995). Although there is a contro-Tohoku University School of Medicine
2-1 Seiryo-machi versial report (Fujii et al., 1995), Stat5 is reportedly involved
in IL-2-mediated cell growth signaling (Friedmann et al.,Aoba-ku, Sendai 980-77
Japan 1996). In the case of receptors for IL-3 and granulocyte/
macrophage colony-stimulating factor (GM-CSF), Jak2,
which is associated with the common b chain (bc chain)Summary
of these cytokine receptors (Miyajima et al., 1992), is
activated in response to IL-3 and GM-CSF and involvedWe previously identified a putative signal transducing
in signaling for DNA synthesis and induction of c-mycadaptor molecule, named STAM, that contains an Src
and c-fos (Sakamaki et al., 1992; Quelle et al., 1994;homology 3 (SH3) domain and immunoreceptor tyro-
Watanabe et al., 1996). Stat5 is also activated by Jak2sine-based activation motif (ITAM). In this report, we
and essentially involved in signaling for DNA synthesisdemonstrate the functional significance of STAM in
mediated by IL-3 (Mui et al., 1996). However, there hascytokine-mediated signal transduction. STAM is asso-
been no evidence for involvement of Stat5 in c-mycciated with Jak3 and Jak2 tyrosine kinases via its ITAM
induction mediated by IL-2, IL-3, and GM-CSF. Thereregion and phosphorylated by Jak3 and Jak2 upon
has also been little information about signal transducingstimulation with IL-2 and GM-CSF, respectively. An
molecules involved in the c-myc induction pathway im-SH3 deletion mutant of STAM confers a dominant-
mediately downstream of Jak2 and Jak3. Therefore, wenegative effect on DNA synthesis mediated by IL-2
suspected that a signaling molecule(s) other than Stat5and GM-CSF. Furthermore, the wild-type STAM, but
may contribute to c-myc induction and possibly to DNAnot STAM mutants deleted of SH3 and ITAM, signifi-
synthesis in the signaling pathways immediately down-cantly enhances c-myc induction mediated by IL-2 and
stream of Jak2 and Jak3 associated with the cytokineGM-CSF. These results strongly implicate STAM in the
receptors.signaling pathways for cell growth and c-myc induc-
Upon investigation into signaling molecules involvedtion immediately downstream of the Jaks associated
in downstream pathways of tyrosine kinases associatedwith the cytokine receptors.
with IL-2 receptor, we detected several molecules that
are tyrosine phosphorylated rapidly after IL-2 stimula-Introduction
tion of cells and succeeded in purification of one of these
molecules, a 70 kDa phosphotyrosine protein. Subse-A variety of cytokine receptors are associated with pro-
quently, we molecularly cloned a cDNA encoding the 70tein tyrosine kinases such as the Janus kinase (Jak), Src
kDa phosphotyrosine protein. We further demonstratedfamilies, and others (Taniguchi, 1995). Upon cytokine-
that the 70 kDa phosphotyrosine protein, which wemediated activation of these kinases, a number of cellu-
named STAM, contains an Src homology 3 (SH3) domainlar proteins, including the receptor subunits and the
and a tyrosine cluster region including an immunorecep-signal transducers and activators of transcription (Stats),
tor tyrosine-based activation motif (ITAM) (Takeshita etare phosphorylated (Ihle et al., 1995). In the case of
al., 1996). This unique structure of STAM suggests thatinterleukin-2 (IL-2) receptor, tyrosine kinases such as
STAM is a novel type of signal transducing adaptor mol-those in the Src family (Lck, Fyn, or Lyn), Jak1, and Syk
ecule, which maybe involved in intracellularsignal trans-are associated with the IL-2 receptor b chain (Hatake-
duction. Although STAM was found to be tyrosine phos-yama et al., 1991; Torigoe et al., 1992; Kobayashi et al.,
phorylated upon stimulation with a variety of cytokines,1993; Tanaka et al., 1994; Miyazaki et al., 1994; Minami et
including IL-2, IL-3, IL-4, IL-7, GM-CSF, epidermal cellal., 1995), and Jak3 is associated with the IL-2 receptor g
growth factor (EGF), and platelet-derived growth factorchain (gc chain) (Kirken et al., 1994; Johnston et al.,
(PDGF), its biological significance had not been eluci-1994; Miyazaki et al., 1994; Asao et al., 1994), which is
dated (Takeshita et al., 1996). The present study pro-shared among several cytokine receptors (Kondo et al.,
vides evidence that STAM is involved in DNA synthesis1993; Russell et al., 1993; Noguchi et al., 1993; Kondo
and c-myc induction mediated by IL-2 and GM-CSF.et al., 1994; Giri et al., 1994; Kimura et al., 1995). These
tyrosine kinases associated with the IL-2 receptor are
activated in response to IL-2 (Sugamura et al., 1995). Results
IL-2-induced Lck activation is involved in signaling for
c-fos induction (Minami et al., 1993). Syk was shown to IL-2-Induced Tyrosine Phosphorylation of STAM
in MOLT4 Transfectants with Various Mutantsbe related to signaling for c-myc induction (Minami et
al., 1995), but we detected IL-2-induced expression of of the IL-2 Receptor b Chain
To search for the tyrosine kinase catalyzing STAM andc-myc expression in a Syk-negative cell line, suggesting
the possible existence of a signaling pathway for c-myc explore the relationship between STAM phosphorylation
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Figure 2. Tyrosine Phosphorylation of STAM by Jak FamilyTyrosine
Kinases
Simian fibroblastoid COS7 cells were transiently transfected with
10 mg of DNA of Jak3, Jak2, Jak1, Lck, or pEF-BOS control plasmid
togetherwith 10mg of DNAof human IL-2 receptor b and gc plasmids
(A) and 10 mg of DNA of human GM-CSF receptor a and bc plasmids
(B), in addition to 10 mg of DNA of pCXSTAM by electroporation.
The cells were preincubated for 24 hr and stimulated with IL-2 (A)Figure 1. IL-2-Induced Tyrosine Phosphorylation of STAM in
and GM-CSF (B) for 10 min. Subsequently, the cells were immuno-MOLT4 Transfectants with the Wild Type and Mutants of the IL-2
precipitated with anti-STAM MAb (TUS-1) and then immunoblottedReceptor b Chain
with anti-phosphotyrosine MAb (4G10) or anti-STAM MAb. Arrow-(A) The schematic structures of the wild-type (wild), A mutant (dA),
heads indicate the wild-type STAM.box1 mutant (79S), and S mutant (dS) of the human IL-2 receptor
b chain are shown. The shaded boxes indicate transmembrane do-
mains. The A mutant and S mutant are deleted from the acidic transfectants (our unpublished data). Therefore, the IL-
region (Gln-313±Leu-382) and serine-rich region (Ser-267±Ser-322), 2-induced tyrosine phosphorylation of STAM correlated
respectively. The box1 mutant contains substitution of Pro-257 and
well with Jak3 activation but not activation of other tyro-Pro-259 for serines.
sine kinases such as Lck (Fyn or Lyn), Syk, and Jak1,(B) MOLT4 transfectants with the wild-type, A mutant, box1 mutant,
which are known to be associated with IL-2 receptor.and S mutant of the human IL-2 receptor b chain were incubated
with (plus) or without (minus) 10 nM human recombinant IL-2 for 10 Since MOLTb, MOLTbdA-6, and MOLTb79S-3, unlike
min. The cell lysates were lysed, and the lysates were immunopre- MOLTbdS-46 cells, are responsive to IL-2 for their growth
cipitated with anti-STAM MAb, TUS-1, which was prepared against (Higuchi et al., 1996), the tyrosine phosphorylation of
the glutathione S-transferase (GST) fusion protein of human STAM
STAM also correlated with IL-2-induced cell growth sig-(amino acid positions 139±222). The immunoprecipitates were sepa-
naling. These observations suggest that STAM is possi-rated by SDS±PAGE and blotted with anti-phosphotyrosine MAb or
bly catalyzed by Jak3, which is known to be essentialTUS-1. Arrowheads indicate STAM.
for IL-2-mediated cell growth signal transduction.
Involvement of Jak3 and Jak2 in Tyrosineand cell growth, we examined MOLT4 transfectants ex-
pressing various mutants of the IL-2 receptor b chain Phosphorylation of STAM
A couple of other interesting insights have been pro-for their ability to induce tyrosine phosphorylation of
STAM upon IL-2 stimulation. MOLTb, MOLTbdA-6, and vided from STAM stimulation. First, STAM was shown
to be tyrosine phosphorylated upon stimulation with IL-3MOLTb79S-3, which are MOLT4 transfectants express-
ing the wild-type, acidic region deletion mutant (A mu- and GM-CSF (Takeshita et al., 1996) and, second, Jak2
activation was essential for cell growth signal transduc-tant), and box1 mutant of the b chain, respectively,
showed appreciable tyrosine phosphorylation of STAM tion from their receptors (Quelle et al., 1994; Watanabe et
al., 1996). Therefore, we further examined the possibilityin response to IL-2, but MOLTbdS-46 expressing the
serine-rich region deletion mutant (S mutant) of the b that Jak3 and Jak2 catalyze phosphorylation of STAM
upon stimulation of cells with IL-2 and GM-CSF, respec-chain did not (Figure 1). STAM was usually detected as
doublet bands. The A mutant lost the ability for associa- tively, by using COS7 cells exogenously introduced with
receptors for IL-2 and GM-CSF and the Jaks or Lck astion and activation of Lck (Fyn or Lyn) (Hatakeyama et
al., 1991; Kobayashi et al., 1993), the box1 mutant lost a control. COS7 cells were transiently transfected with
Jak3, Jak2, Jak1, and Lck, together with the IL-2 recep-the ability for association and activation of Jak1, but not
Jak3 (Higuchi et al., 1996), the S mutant lost the ability tor b and gc chain genes or the GM-CSF receptor a and
bc chain genes, and stimulated with IL-2 or GM-CSF,for activation of Jak1 and Jak3 (Miyazaki et al., 1994),
and Syk expression was undetectable in the MOLT4 respectively. Their lysates were immunoprecipitated
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Figure 3. Tyrosine Phosphorylation of the
Wild Type and STAM Mutants by Jak3 and
Jak2 Kinases
(A) Schematic structures of the wild type and
mutants of STAM. DSH3, DIT, and DY2 mu-
tants of STAM are deleted of the SH3 domain
(Ala-217±Ala-266), ITAM (Glu-356±Leu-387),
and tyrosine cluster region (Tyr-371±Leu-
540), respectively. The closed boxes, shaded
boxes, and Y letters indicate the SH3 domain,
ITAM, and tyrosine residues, respectively.
(B and C) COS7 cells were transiently trans-
fected with 10 mg of DNA each of pCXSTAM,
pCXDSH3,pCXDIT, or pCXDY2, togetherwith
a combination of 10 mg of DNA of human IL-2
receptor b and gc plasmids and 10 mg of DNA
of Jak3 or pSRa (control plasmid) or, in (C),
a combination of 10 mg of DNA of human GM-
CSF receptor a and bc plasmids and 10 mg
of DNA of Jak2 or pEF-BOS (control plasmid)
by electroporation. The cells were preincu-
bated for 24 hr and stimulated with IL-2 (B)
and GM-CSF (C) for 10 min. Subsequently,
the cells were immunoprecipitated with anti-
STAM MAb (TUS-1) and then immunoblotted
with anti-phosphotyrosine MAb (4G10) (up-
per panels) or TUS-1 (lower panels).
with anti-STAM monoclonal antibody (MAb) and immu- 3B and 3C). Expression levels of the wild type and STAM
mutants in the COS7 cells transiently transfected werenoblotted with anti-phosphotyrosine MAb. Although ty-
rosine phosphorylation of STAM was apparently in- not significantly different among the transfections as
shown in the immunoblots (Figures 3B and 3C). Bandsduced in cells transfected with Jak3 and Jak2 before
ligand stimulation, it was significantly increased after corresponding to the wild-type STAM detected with
transfectants of the STAM mutants are thought to beligand stimulation (Figure 2). However, faint tyrosine
phosphorylation of STAM was seen in cells transfected derived from endogenous STAM in COS7 cells (Figures
3B and 3C). These results indicate that the ITAM regionwith Jak1, whereas it was undetectable in cells trans-
fected with Lck (Figure 2). The tyrosine kinases intro- of STAM is required for tyrosine phosphorylation of
STAM by Jak3 and Jak2.duced were confirmed to be significantly expressed
(data not shown). These results suggest that both Jak3
and Jak2 play essential roles in the mechanism(s) culmi- Association of STAM with Jak3 and Jak2
To investigate the direct interaction between STAM andnating in the tyrosine phosphorylation of STAM.
To define the critical region of STAM for its tyrosine Jak3 or Jak2, we performed coimmunoprecipitation as-
says. Since Syk tyrosine kinase associated with IL-2phosphorylation by Jak3 and Jak2, we prepared three
distinct STAM mutants: DSH3 with deletion of the SH3 receptor was previously demonstrated to interact with
the ITAM regions of Iga and Igb chains (Weiss and Litt-domain, DIT with deletion of the ITAM, and DY2 with
deletion of the tyrosine cluster region (Figure 3A). COS7 man, 1994), Syk was also examined for association with
STAM, which also contains the ITAM region. A humancells were transiently transfected with the wild type or
STAM mutants together with a combination of Jak3 and IL-2-dependent T cell line, ILT-Mat, was incubated with
or without IL-2, and lysates were immunoprecipitatedIL-2 receptor b and gc chain genes or a combination of
Jak2 and GM-CSF receptor a and bc chain genes, and with anti-STAM MAb and then immunoblotted with anti-
Jak3, anti-Jak2, anti-Jak1, anti-Syk, or anti-Lck anti-then stimulated with IL-2 or GM-CSF, respectively. Their
lysates were immunoprecipitated with anti-STAM MAb body. Both Jak3 and Jak2, with 120 kDa and 125 kDa
molecular masses, respectively, were detected in theand immunoblotted with anti-phosphotyrosine MAb. Ty-
rosine phosphorylation of the wild-type STAM and DSH3 immunoprecipitates of STAM irrespective of IL-2 stimu-
lation, but Jak1, Syk, and Lck were undetectable, al-was appreciably induced in the cells transfected with
Jak3 and Jak2, respectively, whereas tyrosine phos- though the coimmunoprecipitation of Jak3 seems to be
increased by IL-2 stimulation (Figure 4). ILT-Mat cellsphorylation of DIT and DY2 was hardly detected (Figures
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of anti-Jak3 antibody in the association between STAM
and Jak3 or to significantly higher expression of Jak2
as compared with Jak3. These speculations are awaiting
confirmation; nevertheless, the results indicate that
STAM is directly associated with Jak3 and Jak2 via its
ITAM region, whereas the SH3 domain of STAM is not
involved in the association. These results are consistent
with those mentioned above that thewild type and DSH3
mutant of STAM are tyrosine phosphorylated, but the DIT
and DY2 mutants are not, suggesting the possibility that
Jak3 and Jak2 directly catalyze phosphorylation of STAM.
STAM Mutants Confer a Dominant-Negative Effect
on DNA Synthesis Mediated by IL-2 and GM-CSF
Since Jak3 and Jak2 are known to play essential roles
in the cell growth signal transduction mediated by IL-2
and GM-CSF, respectively (Kawahara et al., 1995; Wata-
nabe et al., 1996), the direct interaction and phosphory-
lation of STAM with the Jaks suggests a possible
involvement of STAM in the cell growth signaling path-
way from these cytokine receptors. To investigate this
possibility, the wild type and three mutants of STAM
were first examined for their effects on DNA synthesis
mediated by IL-2 or GM-CSF in BAF-B03, a mouse IL-
3-dependent cell line transiently reconstituted with re-Figure 4. Coimmunoprecipitation of Endogenous STAM with Jak3
ceptors for human IL-2 or GM-CSF. BAF-B03 cells wereand Jak2 Kinases
transfected with the wild type, STAM mutants, or theA human IL-2-dependent T cell line, ILT-Mat, was incubated with
(plus) or without (minus) 10 nM IL-2 for 10 min. Lysates of the ILT- control vector together with the human IL-2 receptor b
Mat cells (2.5 3 107) were immunoprecipitated with anti-STAM, anti- and gc chain genes and then stimulated with human
B19 human parvovirus as a control, and anti-Jak1 MAbs, or lysates recombinant IL-2. The transfectant cells with the con-
of the ILT-Mat cells (2.5 3 106) were immunoprecipitated with anti-
trol vector for STAM showed a significant increase ofJak3, anti-Jak2, anti-Syk, and anti-Lck antibodies. The immunopre-
[3H]thymidine incorporation in response to IL-2, compa-cipitates were then separated by SDS±PAGE and immunoblotted
rable with the transfectants containing the wild type andwith anti-Jak3, anti-Jak2, anti-Jak1, anti-Syk, and anti-Lck antibod-
ies. Arrowheads indicate Jak3, Jak2, Jak1, Syk, and Lck, respec- DIT and DY2 mutants of STAM (Figure 6A). However,
tively. transfection with DSH3 mutant resulted in 65% decline
in [3H]thymidine incorporation mediated by IL-2 as com-
pared with the control (Figure 6A). The suppression of
were confirmed to express Jak3, Jak2, Jak1, Syk, and IL-2-induced [3H]thymidine uptake was dose dependent
Lck by immunoprecipitation and immunoblotting with on DSH3 plasmids (Figure 6B). Similar results were ob-
each antibody (Figure 4). However, Jak1 expression was tained with the GM-CSF stimulation system. BAF-B03
extremely reduced compared with Jak3, Jak2, Syk, and cells were transfected with the STAMs together with the
Lck, as a more than 10-fold excess amount of ILT-Mat human GM-CSF receptor a and bc chain genes and
lysate was required for detection of Jak1 (Figure 4). These stimulated with human recombinat GM-CSF. The trans-
results suggest a direct association of STAM with Jak3 fectants with the wild type and DIT and DY2 mutants of
and Jak2 even before ligand stimulation of cells, but not STAM induced similar levels of increase in [3H]thymidine
with Jak1, Syk, and Lck in IL-2-responsive ILT-Mat cells. incorporation upon stimulation with GM-CSF as com-
To define the region of STAM participating in the asso- pared with the control vector, whereas the transfectant
ciation with Jak3 and Jak2, we carried out coimmuno- with DSH3 mutant showed 62% suppression of [3H]thy-
precipitation between the STAM mutants and the Jaks. midine incorporation (Figure 6C), dose dependent on
COS7 cells were transiently transfected with the wild DSH3 plasmids (Figure 6D). These results suggest that
type or STAM mutants together with Jak3 or Jak2. Ly- DSH3 mutant of STAM acts as a dominant negative for
sates of the transfected COS7 cellswere immunoprecip- the intrinsic STAM, which is involved in the cell growth
itated with anti-STAM MAb and then immunoblotted signal transduction from receptors for IL-2 and GM-CSF.
with anti-Jak3 or anti-Jak2 antibody. Whereas both Jak3 The dominant-negative effect of DSH3 mutant may be
and Jak2 were apparently coimmunoprecipitated with ascribed to competitive binding of the Jaks between
the wild type and DSH3 mutant, they were undetectable the intrinsic STAM and DSH3 mutant.
or faint in the transfectants with the DIT and DY2 STAM
mutants (Figure 5A and 5B). Conversely, the wild type
and DSH3 mutant were coimmunoprecipitated with at Involvement of STAM in c-myc Induction
Mediated by IL-2 and GM-CSFleast Jak2,but the DIT and DY2 mutants were not (Figure
5D). STAM was also not detected in the immunoprecipi- Accumulating evidence has implicated Jak3 and Jak2
in induction of proto-oncogenes such as c-myc and c-fostates of Jak3 (Figure 5C), possibly due to interference
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Figure 5. Coimmunoprecipitation of the Wild
Type and STAM Mutants with Jak3 and Jak2
COS7 cells were transiently transfected with
10 mg of DNA each of pCXSTAM, pCXDSH3,
pCXDIT, or pCXDY2, together with 10 mg of
DNA of Jak3, Jak2, or control plasmids by
electroporation. The cells were incubated for
24 hr, and their lysates were immunoprecipi-
tated with anti-STAM MAb and then immu-
noblotted with anti-Jak3, anti-Jak2, and anti-
STAM antibodies (A and B). Alternatively,
their lysates were immunoprecipitated with
anti-Jak3 and anti-Jak2 antibodies and then
immunoblotted with anti-STAM, anti-Jak3,
and anti-Jak2 antibodies (C and D).
in response to IL-2 and GM-CSF, respectively (Kawa- mediated by IL-2 and GM-CSF, suggesting the involve-
ment of STAM in signal transduction for c-myc inductionhara et al., 1995; Watanabe et al., 1996). We hence as-
sessed the functional significance of STAM in signaling mediated by these cytokines. Both the SH3 domain and
ITAM seem essential for such signal transduction. Wefor induction of c-myc and c-fos mediated by IL-2 and
GM-CSF. BAF-B03 cells preincubated without IL-3 and have not yet defined the experimental conditions for
detection of dominant-negative effects of STAM mu-fetal calf serum (FCS) were transfected with the wild
type, STAM mutants, or control vector, together with tants inour c-mycpromoter±driven luciferase assay sys-
tem; nevertheless, the results under the present systemthe human IL-2 receptor b and gc chain genes and the
c-myc promoter±driven luciferase gene, and then stimu- were reproducible and hence reliable. The wild-type
STAM conferred marginal effects on c-fos promoter±lated with human recombinant IL-2. The transfectant
cells with the wild-type STAM showed a dramatic in- driven luciferase activities mediated by IL-2 and GM-
CSF (data not shown).crease of 39-fold luciferase activityupon IL-2 stimulation
compared with a barely 6-fold increase with the control
vector, whereas the transfectant cells with DSH3, DIT,
and DY2 mutants showed increases similar to the con- Discussion
trol vector (Figure 7A). The enhancement of IL-2-medi-
ated c-myc induction was dose dependent on the wild- The results of the present study suggest that a novel
type of signal transducing adaptor molecule namedtype STAM plasmids (Figure 7B). Similar results were
obtained with theGM-CSF stimulation system. BAF-B03 STAM is implicated in intracellular signal transduction
mediated by IL-2 and GM-CSF. STAM was originallycells preincubated were transfected with the wild-type,
STAM mutants, or the control vector, together with the identified and molecularly cloned as a phosphotyrosine
protein detected in cells stimulated with IL-2 (Takeshitahuman GM-CSF receptor a and bc chain genes and the
c-myc reporter gene, and then stimulated with human et al., 1996). The IL-2 receptor gc and GM-CSF receptor
bc chains are associated with Jak3 and Jak2, respec-recombinant GM-CSF. Transfection with the wild-type
STAM resulted in a 65-fold increase in c-myc induction tively, which are indispensable for signal transduction
for cell growth and induction of proto-oncogenes suchuponstimulation with GM-CSF, whereas the control vec-
tor and DSH3, DIT, and DY2 mutants induced signifi- as c-myc and c-fos (Asao et al., 1993, 1994; Miyazaki
et al., 1994; Quelle et al., 1994; Kawahara et al., 1995;cantly lower increases of luciferase activity as compared
with the wild-type STAM (Figure 7C). The wild-type Higuchi et al., 1996).
The results of our coimmunoprecipitation studies pro-STAM±mediated activation of luciferase activity upon
stimulation with GM-CSF was dose dependent on its vided direct evidence for the association of STAM with
Jak3 and Jak2, but not with other tyrosine kinases suchplasmid DNA (Figure 7D). These results indicate that the
wild-type STAM strongly potentiates c-myc induction as Jak1, Lck, and Syk, which are also known to be
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exclude the possibility that STAM marginally interacts
with Jak1 when STAM and Jak1 are exogenously over-
expressed. Furthermore, tyrosine phosphorylation of
STAM in MOLT4 transfectants with the IL-2 receptor b
mutants correlated well with activation of Jak3 (but not
Jak1, Lck, and Syk) and induction of DNA synthesis in
response to IL-2. All of these results suggest that STAM
is involved in the signaling immediately downstream of
Jak3 and Jak2 for induction of DNA synthesis. This con-
cept was further confirmed by the fact that the SH3
deletion mutant of STAM, DSH3, which also associates
with the Jaks, significantly suppressed DNA synthesis
mediated by IL-2 or GM-CSF in BAF-BO3 cells reconsti-
tuted with the cytokine receptors and eventually con-
ferred a dominant-negative effect resulting from com-
petitive binding of the Jaks with the endogenous STAM.
These observations suggest that the Jak±STAM path-
way is implicated in signaling for DNA synthesis medi-
ated by IL-2 and GM-CSF. However, the Jak±STAM
pathway for DNA synthesis from the cytokine receptors
is not completely inhibited by DSH3 mutant, suggesting
that a minor alternative pathway may exist. The possibil-
ity that the DSH3 mutant completely inhibits DNA syn-
thesis mediated by the cytokines under as yet unspeci-
fied conditions cannot, however, be excluded.
The wild-type STAM, but not the DSH3, DIT, and DY2
mutants, was found to enhance expression of the c-myc
promoter±driven luciferase gene in BAF-B03 cells starved
of IL-3 and FCS, suggesting that STAM is also implicated
in signaling for c-myc induction mediated by IL-2 and
GM-CSF and that both the SH3 domain and ITAM region
of STAM are required for such signal transduction. The
requirement of the ITAM region in signaling for c-myc
induction is consistent with the notion that both Jak3
and Jak2 play essential roles in c-myc induction medi-
ated by IL-2 and GM-CSF (Kawahara et al., 1995; Wata-
nabe et al., 1996). We failed to establish the optimum
conditions for detection of a dominant-negative effect ofFigure 6. Effect of STAM on [3H]Thymidine Incorporation of BAF-
BO3 Cells in Response to IL-2 and GM-CSF STAM mutants in the c-myc promoter±driven luciferase
assay. This may stem from the fact that the incubationBAF-B03 cells maintained in the medium containing IL-3 were tran-
siently transfected with 10 mg of DNA each of pCXSTAM, pCXDSH3, period after gene transfection has to be shorter in the
pCXDIT, pCXDY2, or pCXN2 (control plasmid) (A and C) or with luciferase assay (11 hr) than in the DNA synthesis assay
combinations of the indicated DNA doses of pCXDSH3 and pCXN2 (24 hr) to maintain a reasonably viable cell number. On
(B and D), together with 2 mg of DNA of human IL-2 receptor b and
the other hand, in our luciferase assay, since expression
gc plasmids (A and B) or 2 mg of DNA of human GM-CSF receptor
of endogenous STAM in BAF-B03 cells is significantlya and bc plasmids (C and D) by electroporation. Subsequently, the
decreased during incubation without IL-3 and FCS (datacells were cultured for 24 hr with (plus) or without (minus) IL-2 (A
and B) in the presence of anti-mouse IL-2 receptor a chain (PC61) not shown), transfection of the wild-type STAM presum-
and b chain (TUm122) MAbs, or with (plus) or without (minus) GM- ably contributes to increasing the expression of STAM,
CSF (C and D), in RPMI 1640 medium containing 0.01% BSA, and which ultimately stimulates the signal transduction for
assayed for [3H]thymidine incorporation for the last 4 hr of cultiva-
expression of the c-myc promoter±driven luciferasetion. The values shown are means 6 SEM of triplicate cultures.
gene.Results represent one of three comparable experiments.
So far, Stat5 is also known to be phosphorylated and
activated by Jak3 and Jak2 and to participate in signal-
associated with the receptor for IL-2 or GM-CSF (Tani- ing for DNA synthesis mediated by IL-2 (Friedmann et
guchi, 1995). STAM was also revealed to be more signifi- al., 1996) and IL-3 (Mui et al., 1996). Hence, it is possible
cantly tyrosine phosphorylated by Jak3 and Jak2 upon that both the Jak±STAM and Jak±Stat5 pathways are
stimulation with IL-2 and GM-CSF than without stimula- required for induction of DNA synthesis mediated by IL-2
tion in COS7 cells reconstituted with the cytokine recep- and IL-3, and probably by GM-CSF, which shares the
tors, suggesting that the tyrosine phosphorylation of bc chain of its receptor with IL-3 (Miyajima et al., 1992).
STAM is directly catalyzed by Jak3 and Jak2. However, However, there has been no evidence for involvement
since a faint band representing tyrosine phosphorylation of Stat5 in signaling for c-myc induction mediated by
of STAM was seen in COS7 cells transfected with Jak1 IL-2 and GM-CSF. Little is also known about functional
molecules contributing to signaling for c-myc inductionupon stimulation with IL-2 and GM-CSF, we can not
A Novel Type of Signal Transducing Adaptor Molecule
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Figure 7. Effect of STAM on Induction of
c-myc in Response to IL-2 and GM-CSF
BAF-B03cells starved of IL-3 and FCS for 9 hr
were transfected with pCXSTAM, pCXDSH3,
pCXDIT, pCXDY2, and pCXN2 (A and C) or
with combinations of pCXSTAM and pCXN2
(B and D), together with human IL-2 receptor
b and gc plasmids (A and B) or together with
human GM-CSF receptor a and bc plasmids
(C and D), in addition to pHXLuc and pENL
by electroporation. Subsequently, the cells
were stimulated with (plus) or without (minus)
human recombinant IL-2 in the presence of
anti-mouse IL-2 receptor a chain (PC61) and
b chain (TUm122) MAbs (A and B), or with
(plus) or without (minus) human recombinant
GM-CSF (C and D), in RPMI 1640 medium
containing 0.01% BSA for 11 hr, and assayed
for luciferase activity. The luciferase activities
were displayed after correction of protein
concentration and b-galactosidase activity of
cell lysates. The values shown are means 6
SEM of triplicate determinants. Results rep-
resent one of three comparable experiments.
downstream of theJaks associated with cytokine recep- SH3 domain of STAM in intracellular signal transduction,
molecules associated with this domain should play im-tors. In this regard, STAM should be the first molecule
portant roles in the signaling pathway. The functionalinvolved in the signal transduction for c-myc induction.
analysis of such molecules should lead tounderstandingSTAM contains the SH3 domain and ITAM, which are
the downstream signaling pathway of Jak±STAM.thought to interact with molecules containing SH3-bind-
Although it is still obscure whether the tyrosine phos-ing sites composed of Pro-Xaa-Xaa-Pro amino acid se-
phorylation of STAM is essential for downstream signalquence (Ren et al., 1993) and a pair of SH2 domains,
transduction, we envisage that it could be an essentialrespectively (Hutchcroft et al., 1992; Chan et al., 1992;
marker for functional association between STAM andIwashima et al., 1994). The ITAM region of STAM was
Jak3 or Jak2. The induction of tyrosine phosphorylationshown to contribute to association with Jak3 and Jak2.
of STAM upon stimulation with other cytokines, includ-Although Jak3 and Jak2 do not contain a pair of SH2
ing IL-3, IL-4, IL-7, EGF, and PDGF (Takeshita et al.,domains, the ITAM of STAM contains amino acid se-
1996), all of which are known to activate the Jak familyquences of Tyr-Xaa-Lys-Xaa, which have been fre-
kinases (Silvennoinen et al., 1993; Shual et al., 1993;quently detected in the sequences of catalytic sites for
Witthuhn et al., 1994; Kirken et al., 1994; Vignais et al.,Jak3 and Jak2 (Ihle et al., 1995; Stahl et al., 1995). Hence,
1996), is intriguing and implicates STAM as a commonthe association between STAM and the Jaks may be
signal transducing adaptor molecule involved in cellulardue to enzyme and substrate interactions. Alternatively,
responses to a wide variety of cytokines other thanthe association of Jak3 with STAM in IL-2-responsive
IL-2 and GM-CSF.ILT-Mat cells was detectable before stimulation with
IL-2, but apparently enhanced by IL-2 stimulation for 10
Experimental Proceduresmin, suggesting another unknown mechanism of associ-
ation between STAM and the Jaks. The IL-2 receptor b Plasmids
chain has been reported to be associated with Syk, Gene expression plasmids used here were pSRB5 for the human
IL-2 receptor b chain (Takeshita et al., 1992a), pSRG1 for the humanwhich contains a pair of SH2 domains (Minami et al.,
IL-2 receptor gc chain (Takeshita et al., 1992b), Prk5Jak1 and1995); however, the present data suggest noassociation
Prk5Jak3 for mouse Jak1 and Jak3, respectively, pEF-BOSJak2of Syk with STAM. We have already identified at least
plasmid for mouse Jak2, pME-lck plasmid for human Lck, pENL
two molecules associated with the SH3 domain of for the b-galactosidase, and human GM-CSF receptor a and bc
STAM, functions of which are, however, still unknown. plasmids. pHXLuc is a luciferase reporter plasmid containing a chi-
mera between the luciferase gene and the human c-myc promoterSince the present study indicates the involvement of the
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